Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: J Card Fail. 2021 Feb 5;27(5):602–606. doi: 10.1016/j.cardfail.2021.01.018

Table 2.

Clinical outcomes stratified by mechanical ventilation utilization

Endpoint Adjusted Odds Ratio (95% CI) * P Value
30-day HF rehospitalization 2.03 (1.29–3.21) 0.002
30-day mortality 10.40 (7.22–14.98) <0.001
60-day mortality 7.68 (5.50–10.74) <0.001
  Ischemic HF 7.84 (4.81–12.76) <0.001
  Non-ischemic HF 7.89 (4.87–12.44) <0.001
  EF ≥ 40% 8.84 (3.64–21.49) <0.001
  EF < 40% 7.94 (5.26–11.99) <0.001

CI = Confidence interval; HF = Heart failure; EF = Ejection fraction

*

Adjusted for trial enrollment, age, race, ischemic heart disease, smoking history (yes, no), cerebrovascular disease, hypertension, atrial fibrillation/flutter, peripheral vascular disease, chronic obstructive lung disease, diabetes mellitus, depression, heart rate, systolic blood pressure, edema, jugular venous distension, rales, sodium, and blood urea nitrogen.